AlphaCrest Capital Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-27,320
Closed -$4.54M 997
2022
Q3
$4.54M Buy
27,320
+16,228
+146% +$3.3M 0.28% 32
2022
Q2
$2.29M Buy
11,092
+6,172
+125% +$1.39M 0.11% 262
2022
Q1
$1.19M Sell
4,920
-1,833
-27% -$425K 0.07% 462
2021
Q4
$1.64M Buy
6,753
+1,460
+28% +$334K 0.06% 548
2021
Q3
$1.08M Buy
5,293
+1,172
+28% +$251K 0.06% 589
2021
Q2
$850K Buy
4,121
+1,715
+71% +$345K 0.04% 740
2021
Q1
$458K Buy
+2,406
New +$446K 0.03% 837
2020
Q4
Sell
-1,500
Closed -$264K 1262
2020
Q3
$264K Sell
1,500
-631
-30% -$101K 0.03% 929
2020
Q2
$327K Sell
2,131
-3,171
-60% -$483K 0.05% 588
2020
Q1
$742K Buy
5,302
+1,184
+29% +$177K 0.09% 398
2019
Q4
$628K Sell
4,118
-3,427
-45% -$502K 0.05% 630
2019
Q3
$1.09M Buy
7,545
+4,204
+126% +$628K 0.07% 526
2019
Q2
$497K Buy
+3,341
New +$446K 0.04% 705
2019
Q1
Sell
-2,000
Closed -$214K 950
2018
Q4
$214K Buy
+2,000
New +$223K 0.06% 577

Other funds holding STE

AlphaCrest Capital Management's STE Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Steris (STE) in Q4 2022, closing a stake of 27,320 shares — an estimated $4.54M sold.

AlphaCrest Capital Management first reported a position in STE in Q4 2018 and held it in 14 quarters. The position peaked at $4.54M in Q3 2022. 648 funds tracked by Wall St. Rank hold STE as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Steris position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 27,320 Steris shares in Q4 2022, an estimated $4.54M.
  • AlphaCrest Capital Management first reported a position in Steris in Q4 2018 and held it in 14 quarters.
  • AlphaCrest Capital Management's Steris position peaked at $4.54M in Q3 2022.
  • 648 funds tracked by Wall St. Rank held Steris as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.